EXTRANODAL NK/T-CELL LYMPHOMA
Clinical trials for EXTRANODAL NK/T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new EXTRANODAL NK/T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for EXTRANODAL NK/T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare lymphoma: experimental drug targets tough cases
Disease control OngoingThis study tests an experimental drug called IMC-001 in 23 adults with a rare type of blood cancer (extranodal NK/T-cell lymphoma) that has returned or stopped responding to previous treatments. The goal is to see if the drug can shrink tumors and how safe it is. Participants rec…
Matched conditions: EXTRANODAL NK/T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: ImmuneOncia Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 06:41 UTC
-
Engineered donor cells take aim at Hard-to-Treat blood cancers
Disease control OngoingThis early-phase study tests a new type of CAR T-cell therapy made from donor cells (WU-CART-007) for people with CD7-positive blood cancers, including acute myeloid leukemia and T-cell lymphoma that have not responded to standard treatments. The therapy is designed to target and…
Matched conditions: EXTRANODAL NK/T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 19, 2026 11:47 UTC